<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="156258">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01735292</url>
  </required_header>
  <id_info>
    <org_study_id>0209-12-HMO</org_study_id>
    <nct_id>NCT01735292</nct_id>
  </id_info>
  <brief_title>Safety of the Automatic Respiration Transfer System- Timer</brief_title>
  <acronym>Timer</acronym>
  <official_title>Safety of the Automatic Respiration Transfer System- Timer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shaare Zedek Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <oversight_info>
    <authority>Israel: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Israel Terminally Ill Law, 2005 allows patients who are terminally ill and ventilated to
      have their ventilator placed on a timer which at a specific time in the future stops the
      ventilator, maintains the patient on positive pressure (CPAP) and allows the patient not to
      be reconnected to the ventilator. We will evaluate the safety of the Automatic Respiration
      Transfer-Timer by assessing vital signs, oxygenation and ventilatory pressures and volumes
      during the use of the timer with the regular ventilator. In addition, we will evaluate
      whether the timer stops the ventilator and switches to CPAP at the designated time.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">January 2014</completion_date>
  <primary_completion_date type="Anticipated">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label</study_design>
  <primary_outcome>
    <measure>Safety of the Automatic Respiration Transfer System- Timer</measure>
    <time_frame>one year</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Number of Adverse Events</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Intensive Care Patients on a Ventilator</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Automatic Respiration Transfer System- Timer</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ventilated patients with informed consent

        Exclusion Criteria:

          -  Non- ventilated patients
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Charles Sprung, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hadassah Medical Organization</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Charles Sprung, MD</last_name>
    <phone>97226778060</phone>
    <email>charless@ekmd.huji.ac.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hadassah Medical Organization</name>
      <address>
        <city>Jerusalem</city>
        <zip>93588</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Charles Sprung, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>November 2012</verification_date>
  <lastchanged_date>November 23, 2012</lastchanged_date>
  <firstreceived_date>November 19, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hadassah Medical Organization</investigator_affiliation>
    <investigator_full_name>SPRUNG CHARLES</investigator_full_name>
    <investigator_title>Director, General Intensive Care Unit</investigator_title>
  </responsible_party>
  <keyword>Ventilation, timer</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
